During the past decade, Pamukkale University Medical Faculty conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 5 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pamukkale University Medical Faculty" #1 sponsor was "Celgene" with 4 trials, followed by "Pamukkale University" with 3 trials sponsored, "Actelion" with 2 trials sponsored, "Baxalta now part of Shire" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pamukkale University Medical Faculty" #1 collaborator was "Takeda Development Center Americas, Inc." with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Pamukkale University Medical Faculty" are "Chronic Inflammatory Demyelinating Polyradiculoneuropathy" (2 trials), "Anaplastic Large-cell Lymphoma" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Chronic Thromboembolic Pulmonary Hypertension" (1 trials) and "Dizziness" (1 trials). Many other conditions were trialed in "Pamukkale University Medical Faculty" in a lesser frequency.

Most popular intervention types in "Pamukkale University Medical Faculty" are "Drug" (7 trials), "Other" (4 trials), "Biological" (2 trials), "Genetic" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Cyclophosphamide" (2 trials), "HYQVIA" (2 trials), "Rituximab" (2 trials) and "0.25% albumin placebo solution with rHuPH20" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pamukkale University Medical Faculty" are 15 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Pamukkale University Medical Faculty". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Pamukkale University Medical Faculty, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Pamukkale University Medical Faculty, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".